Hépato-Gastro & Oncologie Digestive

Volume 27, supplement 4, Novembre 2020
MICI : vers des prises en charge plus rapides et plus personnalisées
Numéro réalisé avec le soutien institutionnel des laboratoires
Volume 27, supplement 4, Novembre 2020
ÉDITORIAL
But where are we going to stop?
(p.5-7)
Laurent Peyrin-Biroulet
MINI-REVUES
Unmet needs in Ulcerative Colitis
(p.8-13)
Pauline Rivière, David Laharie
New molecules (excluding JAK-STAT): What interests for patients in the future?
(p.14-9)
Arnaud Bourreille
New therapeutic objectives in Inflammatory Bowel Disease – Histological remission in ulcerative colitis and Crohn's disease
(p.20-6)
Benjamin Pariente, Pauline Wils
Can we predict primary non-response to biotherapy in Inflammatory Bowel Disease?
(p.27-32)
Xavier Roblin, Stéphane Paul
Input of combination therapy in the management of Inflammatory Bowel Disease and for which benefit/risk ratio?
(p.33-42)
Camille Meunier, Claire Gay, Gilles Boschetti, Chloé Venturin, Mathias Faure, Bernard Flourié, Stéphane Nancey
Selective and non-selective JAK-STAT in Inflammatory Bowel Disease
(p.43-51)
Mathieu Uzzan, Yoram Bouhnik